Sravanthi Cheeti

5PUBLICATIONS
75CO-AUTHORS
Molecular targetsPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Glycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 27, 2025
PI3Kα Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with PIK3CA-Mutated Solid Tumors and in Preclinical Models.

Dejan Juric, Kyung Song, Radia M Johnson

|Mar 14, 2024
Understanding CYP3A4 and P-gp mediated drug-drug interactions through PBPK modeling - Case example of pralsetinib.

Christine Bowman, Michael Dolton, Fang Ma

|Jun 01, 2023
An Open-label Phase I Study of GDC-0927 in Postmenopausal Women with Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer.

Sarat Chandarlapaty, Maura N Dickler, Jose Alejandro Perez Fidalgo

Pageof 1